Table 2.
Clinical characteristics of the 30 patients in the control group
| No. | Gender | GMFCS stage | Age (years) | LDQ | GMFM |
|---|---|---|---|---|---|
| 1 |
Female |
V |
1 |
72 |
36 |
| 2 |
Female |
III |
2.5 |
35 |
183 |
| 3 |
Male |
III |
3.5 |
28 |
198 |
| 4 |
Male |
III |
4 |
92 |
211 |
| 5 |
Male |
V |
2 |
100 |
35 |
| 6 |
Male |
V |
2 |
38 |
23 |
| 7 |
Male |
V |
4.5 |
15 |
33 |
| 8 |
Male |
IV |
3.5 |
27 |
110 |
| 9 |
Female |
V |
2 |
75 |
51 |
| 10 |
Female |
IV |
2.5 |
82 |
99 |
| 11 |
Male |
IV |
1 |
60 |
80 |
| 12 |
Female |
III |
15 |
95 |
201 |
| 13 |
Female |
III |
1 |
62 |
135 |
| 14 |
Male |
IV |
5 |
86 |
110 |
| 15 |
Female |
IV |
2.5 |
95 |
98 |
| 16 |
Male |
IV |
21 |
98 |
135 |
| 17 |
Male |
IV |
35 |
82 |
90 |
| 18 |
Male |
IV |
9 |
80 |
112 |
| 19 |
Female |
V |
4 |
12 |
30 |
| 20 |
Female |
V |
1 |
23 |
43 |
| 21 |
Male |
V |
1.7 |
25 |
45 |
| 22 |
Female |
V |
1 |
30 |
50 |
| 23 |
Female |
III |
1.5 |
80 |
146 |
| 24 |
Female |
V |
3 |
39 |
25 |
| 25 |
Male |
IV |
2.5 |
96 |
99 |
| 26 |
Male |
V |
2.6 |
100 |
28 |
| 27 |
Female |
III |
2 |
86 |
100 |
| 28 |
Female |
V |
1 |
65 |
45 |
| 29 |
Male |
III |
1.5 |
85 |
125 |
| 30 | Male | V | 1 | 64 | 43 |
The clinical characteristics of the 30 patients in the control group are shown. GMFCS: Gross Motor Function Classification System levels; LDQ: language developmental quotient; GMFM: Gross Motor Function Measurement scores.